Join the Depression group to help and get support from people like you.
Depression News (Page 21)
Related terms: Major Depression, Unipolar Depression
Psychological Resilience Protects Against Earlier Death in Older Adults
THURSDAY, Sept. 5, 2024 – Psychological resilience protects against all-cause mortality in older adults, according to a study published online Sept. 3 in BMJ Mental Health. Aijie Zhang, from the ...
Brain's Wiring May Trigger Depression in Some People
FRIDAY, Sept. 6, 2024 – A distinct brain pattern appears to make some people more likely to develop depression, a new study indicates. “Deep” functional MRI brain scans revealed that a brain feature ...
Suicide Risk Higher for Cancer Patients Not Proceeding With Recommended Surgery
WEDNESDAY, Sept. 4, 2024 – Higher suicide deaths are seen among cancer patients who do not undergo recommended surgery, according to a research letter published online Sept. 3 in JAMA Network Open. ...
Ketamine Can Fight Depression, But Pregnant Women Face Risks
THURSDAY, Sept. 5, 2024 – Ketamine is becoming a popular depression drug, but doctors aren’t keeping in mind the danger it can pose to a pregnancy, a new study warns. Ketamine can be very harmful to ...
Semaglutide Does Not Increase Psychiatric Complications in Overweight, Obesity
TUESDAY, Sept. 3, 2024 – Treatment with semaglutide does not increase the risk for developing symptoms of depression or suicidal ideation/behavior among adults with overweight or obesity, according...
Folks Who Cope, Adapt Do Well in Old Age: Study
WEDNESDAY, Sept. 4, 2024 – People who can cope with challenges as they grow older are more likely to live longer, a new study shows. Seniors with higher levels of mental resilience are 53% less...
Depressed Adolescents Twice as Likely to Take Up Vaping
TUESDAY, Sept. 3, 2024 – A survey of Australian adolescents finds those who are experiencing depressive symptoms have double the risk of taking up vaping. “In the short term, nicotine may reduce f...
Ozempic, Wegovy Won't Raise User's Suicide Risk, Study Finds
TUESDAY, Sept. 3, 2024 – The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or Wegovy. But a new study rules...
Commercial Determinants Linked to Poor Mental Health Outcomes
FRIDAY, Aug. 30, 2024 – There is evidence that commercial determinants or unhealthy commodities like alcohol and social media are associated with poor mental health outcomes, according to a review...
Depression Might Sometimes Be Early Sign of Alzheimer's Disease
FRIDAY, Aug. 30, 2024 – In some people, new-onset depression may stem from the same buildup of toxic plaques in the brain that have long been linked to Alzheimer's disease, according to a new study....
FDA Approves Auvelity (dextromethorphan and bupropion) for the Treatment of Major Depressive Disorder in Adults
Auvelity is the first and only rapid-acting oral treatment approved with labeling of statistically significant improvement in depressive symptoms compared to placebo starting at one week11-4...
Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for Caplyta (lumateperone) for Specific Patient Populations
Caplyta label now includes dosage recommendations for specific patient populations; those with moderate or severe hepatic impairment and patients who are concomitantly taking moderate or strong...
FDA Approves Spravato (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior
TITUSVILLE, N.J. – (August 3, 2020) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug ...
FDA Approves Expanded Use of Vraylar (cariprazine) in the Treatment of Bipolar Depression
DUBLIN and BUDAPEST, Hungary, May 28, 2019 /PRNewswire/ – Allergan plc (NYSE: AGN) and Gedeon Richter Plc. today announced that the U.S. Food and Drug Administration (FDA) has approved a...
FDA Approves Zulresso (brexanolone) for the Treatment of Postpartum Depression
March 19, 2019 -- The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This ...
Further information
Related condition support groups
Major Depressive Disorder, Dysthymia, Sexual Dysfunction, SSRI Induced, Seasonal Affective Disorder, Postpartum Depression
Related drug support groups
Lexapro, tramadol, Zoloft, sertraline, Wellbutrin, Cymbalta, trazodone, Prozac, Effexor, view more... escitalopram, citalopram, bupropion, mirtazapine, Abilify, amitriptyline, venlafaxine, fluoxetine, Celexa, Paxil, alprazolam, Effexor XR, Pristiq, lithium, Wellbutrin XL, Viibryd, duloxetine, lamotrigine, quetiapine, Remeron, nortriptyline, paroxetine, olanzapine, Wellbutrin SR, methylphenidate, risperidone, Zyprexa, modafinil, aripiprazole, Elavil, doxepin, Seroquel XR, Rexulti, clomipramine, ketamine, valerian, fluvoxamine, niacin, desvenlafaxine